• Nenhum resultado encontrado

Arq. NeuroPsiquiatr. vol.75 número7

N/A
N/A
Protected

Academic year: 2018

Share "Arq. NeuroPsiquiatr. vol.75 número7"

Copied!
1
0
0

Texto

(1)

409

https://doi.org/10.1590/0004-282X20170089

EDITORIAL

Following the road of progress in acute

ischemic stroke care

Seguindo o caminho do progresso no tratamento do AVCI agudo

Paulo Puglia Junior1

A

fter decades of delay, if compared to other medical emergencies like myocardial infarction, knowledge about stroke inally achieved a grade that allows interven -tion to change its natural history. hat has been a long road.

he acute stroke phase comprises the irst few hours, when the potential max -imal lesion is not necessarily established yet, creating a time window for intervention.

he use of the intravenous rt-PA is the standard treatment for acute ischemic stroke, with evidence of its beneits for eligible patients. One of the advantages of this approach is the pos -sibility of intervening soon after the patient was assessed. Despite this advantage, only a small proportion of patients beneit from intravenous t-PA, mainly due to its short therapeutic win -dow (≤ 4.5 hours) and poor performance in large vessel occlusion.

Intra-arterial thrombolysis via catheter (IAT) has been performed for more than 30 years, as an alternative or as a adjunctive treatment, but its exact role was not clear until recently, despite teams involved had a positive impression about results, at least in part of patients. New devices were developed to extract the thrombus without or after pharmacological intervention, but the evidence of its beneit remained lacking. In 2013 three negative trials put IAT in great doubt1.

he question had a turning point in 2015, when new randomized clinical trials showed that intra-arterial thrombolysis alone or in combination with IV t-PA was superior to IV t-PA alone, in a selected population of patients harbouring large vessel occlusions2.

Additionally, these trials revealed a set of indicators of performance, which improve -ment is associated with better outcomes, like frequency of complete recanalization and time needed to achieve it.

Part of the efort to improve outcomes by improving the IAT indicators is reported in the present issue3. he possibility of a quicker and more frequent complete vessel recanalization is welcome, along with more widespread availability of these treatment tools in the public hospi -tals, more information to make patients seek help earlier and better recognition and processes of investigation in the emergency rooms. here is a long road of continuous progress in stroke care.

1Universidade de São Paulo,

Faculdade de Medicina, Hospital das Clínicas, Instituto de Radiologia, Neurorradiologia Vascular, São Paulo SP, Brasil.

Correspondence:

Paulo Puglia Junior; Rua Inácio Pereira da Rocha, 486; 05432-011 São Paulo SP Brasil; E-mail: ppuglia@yahoo.com

Conflict of interest:

There is no conflict of interest to declare.

Received 18 June 2017 Accepted 26 June 2017.

References

1. Smith WS, Furlan AJ. Brief history of endovascular acute ischemic stroke treatment.

Stroke. 2016;47(2):e23-6.

https://doi.org/10.1161/STROKEAHA.115.010863

2. Ferri CP, Buehler A, Flato UA, Puglia Junior P, Fernandes JG. Endovascular thrombectomy for t he treatment of acute ischemic stroke.

Arq Neuropsiquiatr. 2016 Jan;74(1):67-74. https://doi.org/10.1590/0004-282X20150182

Referências

Documentos relacionados

aeruginosa showed resistant to kanamycin alone, but a significant reduction in the resistance rate was observed when kanamycin was combined with ciprofloxacin (0%, lowest

Thus, the objective of this study was to evaluate the in vitro antifungal activity of farnesol alone and in combination with antifungal agents against clinical and environmental

The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in

The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in

In a clin ical t rial in Can ada, t he effect iven ess of INH alone and in combination with para-aminosalicylic acid (PAS) in t he preven t ion of TB react ivat ion was est imat

In hearing outcomes in patients with severe hearing loss, combination therapy showed statistically significant hearing improve- ment compared with oral steroid alone, and

In this study, when the use of HBO alone was compared with the untreated group with MRSA mediastinitis, a reduction in the number of bacteria was found; however, when HBO alone

Under the conditions of the present study, it was concluded that pain associated with teeth having necrotic pulps, which were dressed with chlorhexidine alone or in combination